MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage ...

Learn more about a vehicle you own or plan to buy to help avoid any hidden surprises. Check reported thefts and salvage records. Check previously reported mileage. 7 day trial allows you to run up to ...

After hours: 7:58:41 p.m. EST Loading Chart for PLUG ...